Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Overview of attention for article published in Investigational New Drugs, November 1992

Altmetric Badge

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 532 Dimensions

Readers on

mendeley: 65 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Pharmaceutical formulations of ecteinascidin compounds

Grant US-10322183-B2

United States of America

Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related…

Grant US-9192568-B2

United States of America

Pharmaceutical formulations of ecteinascidin compounds

Grant US-8895557-B2

United States of America